International Medical Center of Biomaterials Processing and Cryostorage (MOEX:GEMA)

Russia · Delayed Price · Currency is RUB

672.00

-1.50 (-0.22%)

At close: Jul 8, 2022

MOEX:GEMA Financials Overview

Financials in millions RUB. Fiscal year is January - December.

Millions RUB. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	387.44	376.74	348.6	283.51	254.68	265.89
Revenue Growth	5.37%	8.07%	22.96%	11.32%	-4.22%	9.59%
Gross Profit	309.61	304.04	289.89	235.56	203	204.07
Operating Income	176.12	181.8	178.15	149.36	138.6	137.9
Net Income	128.28	158.39	151.22	125.78	98.17	150.74
Earnings Per Share	7.73	10.61	10.13	8.42	6.58	10.10
EPS Growth	-23.73%	4.74%	20.24%	28.13%	-34.88%	22.79%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	677.23	383.58	323.9	196.07	84.87	36.24
Total Debt	38.67	259.78	271.93	259.93	261.34	55.2
Net Cash (Debt)	638.56	123.79	51.96	-63.86	-176.47	-18.96
Net Cash Growth	816.63%	138.23%	-	-	-	-
Net Cash Per Share	38.46	8.29	3.48	-4.28	-11.82	-1.27

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	193.29	209.91	247.6	223.77	241.11	244.51
Capital Expenditures	-8.32	-5.35	-10.59	-14.18	-9.27	-4.68
Free Cash Flow	184.97	204.55	237.02	209.59	231.83	239.82
Free Cash Flow Growth	-24.89%	-13.70%	13.08%	-9.59%	-3.33%	81.33%

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	79.91%	80.70%	83.16%	83.09%	79.71%	76.75%
Operating Margin	45.46%	48.26%	51.10%	52.68%	54.42%	51.86%
Pretax Margin	33.11%	42.04%	43.38%	44.36%	38.55%	48.58%
Profit Margin	33.11%	42.04%	43.38%	44.37%	38.55%	56.69%
FCF Margin	47.74%	54.30%	67.99%	73.93%	91.03%	90.20%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	10.800	10.800	10.100	6.420	8.022	8.650
Dividend Per Share Growth	-	6.93%	57.32%	-19.97%	-7.26%	-
Dividend Yield	1.61%	-	1.50%	0.95%	1.19%	0.91%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	86.98	-	66.35	79.77	102.20	98.94
P/FCF Ratio	54.24	-	42.33	47.87	43.28	62.19
PS Ratio	25.90	-	28.78	35.39	39.40	56.10